The trade-off is that higher doses later in your protocol will require drawing larger volumes, potentially exceeding the 100-unit syringe capacity at doses above 1mg to 2.5mg depending on concentration
Sensory Symptoms Numbness, tingling, or pins and needles (paresthesia) typically distal/stocking-glove in polyneuropathy Burning pain, allodynia, hyperalgesia common in small-fiber predominant neuropathy and CIDP Loss of proprioception and vibration sense sensory ataxia, positive Romberg sign Loss of pain/temperature sensation (small fiber) risk of unnoticed wounds Motor Symptoms Distal muscle weakness (foot drop in peroneal neuropathy, wrist drop in radial neuropathy) Atrophy of intrinsic hand muscles (ulnar/median neuropathy) Hyporeflexia or areflexia (ankle jerks lost early in length-dependent polyneuropathy) Fasciculations in severe axonal loss Autonomic Symptoms Orthostatic hypotension, dizziness on standing Gastroparesis, constipation or diarrhea, nausea Neurogenic bladder (hesitancy, retention, incontinence) Anhidrosis or gustatory sweating Sexual dysfunction
VitaminB6 I.P
Persistent fatigue or low energy levels Diagnosed B vitamin deficiency Post-illness recovery High stress or mental health support Vegan or vegetarian diet Preparing for major physical activity Experience the Future of Injection Therapy Why Vitamin shots
We are committed to developing our compounds using cutting-edge delivery methods, ensuring their dependability and potency for scientific research applications
Trying to get GLP1 medication covered can feel like a maze
